Are predictive biomarkers of toxicity worth having?? An economic model

Author： Jones Byron   Smith Dennis A.   Schmid Esther F.  

Publisher： Informa Healthcare

ISSN： 1366-5928

Source： Xenobiotica, Vol.42, Iss.1, 2012-01, pp. : 4-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Proteomic approaches to identify biomarkers predictive of radiotherapy outcomes

By Lacombe Jérôme   Azria David   Mange Alain   Solassol Jérôme  

Expert Review of Proteomics, Vol. 10, Iss. 1, 2013-02 ,pp. : 33-42

Informa Healthcare

Access to resources Recommend Favorite

Toxicity assessment of tamoxifen by means of a bacterial model

By Luxo Cristina   Jurado Amália   Madeira Vítor  

Applied Biochemistry and Biotechnology, Vol. 87, Iss. 3, 2000-10 ,pp. : 219-232

Humana Press, Inc

Access to resources Recommend Favorite

Preclinical toxicity biomarkers for combination treatment with clotting factors rFXIII and rFVIIa

By Oleksiewicz M. B.   Schaal-Jensen R.   Kiehr B.   Krabbe J. Steenbuch   Sommer C.  

Biomarkers, Vol. 12, Iss. 4, 2007-07 ,pp. : 424-444

Informa Healthcare

Access to resources Recommend Favorite

Extension of a predictive substrate model for human cytochrome P4502D6

By Groot M. J. De   Bijloo G. J.   Acker F. A. A. Van   Guerra C. Fonseca   Snijders J. G.  

Xenobiotica, Vol. 27, Iss. 4, 1997-04 ,pp. : 357-368

Informa Healthcare

Access to resources Recommend Favorite

Predictive toxicity modelling of benzodiazepine drugs using multiple in silico approaches: descriptor-based QSTR, group-based QSTR and 3D-toxicophore mapping

By Kar Supratik   Roy Kunal  

Molecular Simulation, Vol. 41, Iss. 4, 2015-03 ,pp. : 345-355

Taylor & Francis Ltd

Access to resources Recommend Favorite